Shay Capital LLC Context Therapeutics Inc. Transaction History
Shay Capital LLC
- $606 Million
- Q1 2025
A detailed history of Shay Capital LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Shay Capital LLC holds 189,853 shares of CNTX stock, worth $129,100. This represents 0.02% of its overall portfolio holdings.
Number of Shares
189,853
Previous 50,000
279.71%
Holding current value
$129,100
Previous $49,000
134.69%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CNTX
# of Institutions
48Shares Held
79MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$10 Million1.66% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$5.08 Million1.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$5.05 Million0.16% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$5.05 Million1.06% of portfolio
-
Nextech Invest Ag7.42MShares$5.05 Million1.37% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...